Follow The Filings

MNRO Monro

Monro earnings company data as of 4:47 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.05 — —
Rev — — —

Insider trades

Open-market buys and sales by MNRO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MNRO insider trades
  • $21.3M bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Peter D Fitzsimmons CEO
    Buy
    $251K 12,750 shares at $19.68 +13% to stake
    Traded Feb 5 Filed Feb 9
    ↗
  2. Peter D Fitzsimmons CEO
    Buy
    $251K 13,350 shares at $18.80 +16% to stake
    Traded Feb 3 Filed Feb 5
    ↗
  3. Carl C Icahn 10% owner, +2 joint filers
    Buy
    $11.1M 638,659 shares at $17.38 +14% to stake
    Traded Nov 5–7 Filed Nov 7, 2025
    ↗
  4. Carl C Icahn 10% owner, +2 joint filers
    Buy
    $9.7M 639,473 shares at $15.19 +17% to stake
    Traded Nov 4, 2025 Filed Nov 5, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 21 stock grants, 17 share withholdings for taxes, and 2 sales back to the company.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
8-K 5.07,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.